The members of the ARC leadership team are deeply committed to working together to improve outcomes for amyloidosis patients.
These exceptional individuals have been instrumental in creating and driving the ARC’s excellent programs, making a difference for all types of systemic amyloidosis.
A multidisciplinary team of experts in the field of amyloidosis oversees the ARC’s scientific agenda and strategic direction.
Angela Dispenzieri MD, Mayo Clinic
Raymond Comenzo MD, Tufts Medical School
Eric Low OBE, Myeloma UK
Jeffery Kelly PhD, Scripps Research Institute
Mathew Maurer MD, New York-Presbyterian Hospital
Giampaolo Merlini MD, University of Pavia
Vaishali Sanchorawala MD, Boston Medical Center
Ashutosh Wechalekar MD, Royal Free Hospital